F. Koning

发表

Biological and Molecular Aspects of HIV-1 Coreceptor Usage

H. Schuitemaker, F. Koning, R. Rij, 2003 .

The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.

M. Malim, K. Lemon, B. Rima, 2012, The Journal of general virology.

Human APOBEC3G-Mediated Editing Can Promote HIV-1 Sequence Diversiﬁcation and Accelerate Adaptation to Selective Pressure (cid:1)

M. Malim, Steven Wolinsky, K. Kunstman, 2010 .

Infectionwith Low Susceptibility to HIV-1 T Cell Activation Is + Low-Level CD4

F. Miedema, M. Prins, M. Hazenberg, 2017 .

Low-Level CD4+ T Cell Activation Is Associated with Low Susceptibility to HIV-1 Infection1

H. Schuitemaker, F. Miedema, M. Prins, 2005, The Journal of Immunology.

Infection Associated with Low Susceptibility to HIV-1 T Cell Activation Is + Low-Level CD 4

F. Miedema, M. Prins, M. Hazenberg, 2005 .

Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour

H. Schuitemaker, D. van Baarle, M. Prins, 2004, AIDS.

No Selection for CCR5 Coreceptor Usage during Parenteral Transmission of Macrophagetropic Syncytium-Inducing Human Immunodeficiency Virus Type 1

H. Schuitemaker, D. Schols, F. Koning, 2001, Journal of Virology.

Low Levels of Human Immunodeficiency Virus Type 1 DNA in High-Risk Seronegative Men

H. Schuitemaker, F. Koning, T. J. K. van der Vorst, 2005, Journal of Virology.

APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation

M. Malim, F. Koning, R. K. Holmes, 2007, Journal of Biological Chemistry.

Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets

M. Malim, Eun-Young Kim, Steven Wolinsky, 2009, Journal of Virology.

Determinants of host HIV-1 suspectibility and R5 HIV-1 evolution

F. Koning, 2004 .

Molecular Evolution of Human Immunodeficiency Virus Type 1 upon Transmission between Human Leukocyte Antigen Disparate Donor-Recipient Pairs

H. Schuitemaker, N. Kootstra, M. Navis, 2008, PloS one.

Evolution of CCR5 using human immunodeficiency virus type 1 in relation to CCR5∆32 host genetic background

H. Schuitemaker, F. Koning, 2009 .

Dynamics of HIV type 1 recombination following superinfection.

P. Cane, J. Mbisa, M. Fisher, 2013, AIDS research and human retroviruses.

Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.

H. Schuitemaker, A. Duits, D. van Baarle, 2005, Virology.

Target Cell-Mediated Editing of HIV-1 cDNA by APOBEC3 Proteins in Human Macrophages

M. Malim, C. Goujon, F. Koning, 2011, Journal of Virology.

Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.

H. Schuitemaker, D. Kwa, B. Boeser-Nunnink, 2003, The Journal of infectious diseases.

Human APOBEC3G-Mediated Editing Can Promote HIV-1 Sequence Diversification and Accelerate Adaptation to Selective Pressure

M. Malim, Eun-Young Kim, Tanmoy Bhattacharya, 2010, Journal of Virology.

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors.

P. Cane, D. Dunn, J. Mbisa, 2013, The Journal of antimicrobial chemotherapy.

Sensitivity of Primary R5 HIV-1 to Inhibition by Rantes Correlates with Sensitivity to Small-Molecule R5 Inhibitors

H. Schuitemaker, F. Koning, C. Koevoets, 2005, Antiviral Therapy.

Cellular immunity driving HIV-1 evolution

H. Schuitemaker, M. Navis, F. Koning, 2009 .